National Institute of Allergy and Infectious Diseases (NIAID)
News AdvisoryNIAID Updates “Focus on TB” Web Feature
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has updated “Focus on Tuberculosis (TB)” in advance of World TB Day, March 24. This Web feature describes TB research being done in NIAID’s labs in Bethesda, MD, and by NIAID-supported scientists across the country and around the world.
Every second of every day, someone is newly infected by Mycobacterium tuberculosis, the bacterium that causes TB. The ancient affliction still reigns as one of the world’s leading killers. Yet, there is reason for hope. Visit the Web site to read about research studies in progress such as these:
For these and other story ideas, visit the “Focus on TB” Web site at http://www3.niaid.nih.gov/news/focuson/tb/default.htm.
News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.
NIAID is a component of the National Institutes of Health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies.
The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.